Novo Nordisk A/S (NVO) Social Stream



Novo Nordisk A/S (NVO): $100.70

-1.40 (-1.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Novo Nordisk A S (NVO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NVO.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
23 $86.86 $52.6 $72.51 $100.87 -28.12%

The Trend in the Analyst Price Target


NVO's average price target has moved up $1.71 over the prior 98 days.

NVO reports an average of 7.43% for its upside potential over the past 174 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-26 23 86.86 52.60 72.51 66.14 9.63%
2020-11-18 23 86.86 52.60 72.50 66.52 8.99%
2020-11-11 23 86.86 52.39 72.31 67.70 6.81%
2020-10-30 21 86.52 51.63 72.39 63.89 13.3%
2020-10-05 22 83.46 52.27 71.39 70.12 1.81%
2020-09-26 21 83.46 52.27 71.85 69.06 4.04%
2020-09-18 23 83.46 52.27 72.31 NA NA%
2020-09-05 24 83.46 46.43 70.96 NA NA%
2020-08-27 24 83.46 46.43 70.88 NA NA%
2020-08-20 25 83.46 46.43 70.80 NA NA%
2020-08-12 25 83.46 46.43 70.82 NA NA%
2020-08-07 25 83.46 46.43 70.60 NA NA%
2020-07-23 25 82.76 46.43 68.90 NA NA%
2020-07-16 25 82.76 46.43 68.62 NA NA%
2020-07-09 25 82.76 45.61 68.02 NA NA%
2020-07-02 25 82.76 45.61 67.76 NA NA%
2020-06-25 25 82.76 45.61 67.43 NA NA%
2020-06-20 25 82.76 45.61 67.37 NA NA%
2020-06-11 24 79.65 45.61 66.60 NA NA%
2020-06-05 24 79.65 45.61 66.28 NA NA%

NVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


NVO's average broker recommendation rating improved by 0.04 over the prior 31 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVO as an investment opportunity.

  • Novo Nordisk A S's number of analysts covering the stock is higher than 99.58% of Pharmaceutical Products stocks.
  • Novo Nordisk A S's upside potential (average analyst target price relative to current price) is higher than 1.64% of stocks in the mega market cap category.
  • The average analyst price target of NVO is greater than 87.83% of Pharmaceutical Products stocks.
  • Novo Nordisk A S's variance in analysts' estimates is less than 26.53% of all US stocks.

What is the outlook for NVO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.88 seconds.